BP CC 001

BIOLOGICAL2 trials

Sponsors

BIONCaRT GmbH

Conditions

Cartilage DamageCartilage defect of the knee joint

Phase 1

Phase I/IIa study to test the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the knee joint - BP CC 001

RecruitingCTIS2024-517684-23-00

BIONCaRT GmbHCartilage defect of the knee joint

Start: 2025-10-23Target: 55Updated: 2025-08-12

Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint

RecruitingNCT06981741

BIONCaRT GmbHCartilage Damage

Start: 2025-11-10End: 2028-11-30Target: 55Updated: 2026-01-13